Epithelial-mesenchymal transition and tumor metastasis

Chinese Journal of Lung Cancer

Volumn 14, Issue 7, 2011, Pages 620-624

  Zhao, Rongzhi ^a   Wu, Zhihao ^a   Zhou, Qinghua ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Metastasis; Tumor invasion

Indexed keywords

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CANCER MORTALITY; CANCER PATIENT; CANCER TISSUE; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; FIBROSIS; HUMAN; METASTASIS; MOLECULAR DYNAMICS; TISSUE REGENERATION; WOUND HEALING;

EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASM INVASIVENESS;

EID: 79960576943     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2011.07.11     Document Type: Article

References (46)

1. Lunt SJ, Chaudary N, Hill RP. The tumor microenvironment and metastatic disease. Clin Exp Metastasis, 2009, 26(l): 19-34.
2. Micalizzi DS, Ford HL. Epithelial-mesenchymal transition in development and cancer. Future Oncol, 2009, 5(8): 1129-1143.
3. Micalizzi DS, Farabaugh SM, Ford HL. Epithelial-mesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia, 2010, 15(2): 117-134.
4. Thiery JP, Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. NatRevMol Cell Biol, 2006, 7(2): 131-142.
5. Greenburg G, Hay ED. Epithelia suspended in collagen gels can lose polarity and express characteristics of migrating mesenchymal cells. J Cell Biol, 1982, 95(1): 333-339.
6. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest, 2009, 119(6): 1420-1428.
7. Wu Y, Zhou BP. New insights of epithelial-mesenchymal transition in cancer metastasis. Acta Biochim Biophys Sin (Shanghai), 2008, 40(7): 643-650.
8. Tsuji T, Ibaragi S, Hu GF. Epithelial-mesenchymal transition and cell cooperativity in metastasis. Cancer Res, 2009, 69(18): 7135-7139.
9. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest, 2009, 119(6): 1429-1437.
10. Aizawa H, Tagami H. Delayed tissue necrosis due to mitomycin C. Acta Derm Venereol, 1987, 67(4): 364-366.
11. Miles FL, Pruitt FL, van Golen KL, et al. Stepping out of the flow: capillary extravasation in cancer metastasis. Clin Exp Metastasis, 2008, 25(4): 305-324.
12. Hlubek F, Spaderna S, Jung A, et al. Beta-catenin activates a coordinated expression of the proinvasive factors laminin-5 gamma2 chain and MT1-MMP in colorectal carcinomas. IntJ Cancer, 2004, 108(2): 321-326.
13. Gavert N, Conacci-Sorrell M, Gast D, et al. LI, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers. J Cell Biol, 2005, 168(4): 633-642.
14. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 2004, 117(7): 927-939.
15. Grunert S, Jechlinger M, Beug H. Diverse cellular and molecular mechanisms contribute to epithelial plasticity and metastasis. Nat Rev Mol Cell Biol, 2003, 4(8): 657-665.
16. Rho JK, Choi YJ, Lee JK, et al. Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer, 2009, 63(2): 219-226.
17. Thomson S, Buck E, Petti F, et al. Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res, 2005, 65(20): 9455-9462.
18. Yauch RL, Januario T, Eberhard DA, et al. Epithelial versus mesenchymal phenotype determines in vitro sensitivity and predicts clinical activity of erlotinib in lung cancer patients. Clin Cancer Res, 2005, 11(24 Pt l): 8686-8698.
19. Polette M, Mestdagt M, Bindels S, et al. Beta-catenin and ZO-1: shuttle molecules involved in tumor invasion-associated epithelial-mesenchymal transition processes. Cells Tissues Organs, 2007, 185(1-3): 61-65.
20. Gloushankova NA Changes in regulation of cell-cell adhesion during tumor transformation. Biochemistry (Mosc), 2008, 73(7): 742-750.
21. Blanco D, Vicent S, Elizegi E, et al. Altered expression of adhesion molecules and epithelial-mesenchymal transition in silica-induced rat lung carcinogenesis. Lab Invest, 2004, 84(8):999-1012.
22. Smit ATA, Geiger TR, Song JY, et al. A Twist-Snail axis critical for TrkB-induced epithelial-mesenchymal transition-like transformation, anoikis resistance, and metastasis. Mol Cell Biol, 2009, 29(13): 3722-3737.
23. Cho HJ, Baek KE, Saika S, et al. Snail is required for transforming growth factor-beta-induced epithelial-mesenchymal transition by activating PI3 kinase/Akt signal pathway. Biochem Biophys Res Commun, 2007, 353(2): 337-343.
24. Kurrey NK, K A, Bapat SA. Snail and Slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol, 2005, 97(l): 155-165.
25. Acloque H, Thiery JP, Nieto ATA. The physiology and pathology of the EMT. Meeting on the epithelial-mesenchymal transition. EMBO Rep, 2008, 9(4): 322-326.
26. Bremnes RM, Veve R, Hirsch FR, et al. The E-cadherin cell-cell adhesion complex and lung cancer invasion, metastasis, and prognosis. Lung Cancer, 2002,36(2): 115-124.
27. Stemmer V, de Craene B, Berx G, et al. Snail promotes Wnt target gene expression and interacts with beta-catenin. Oncogene, 2008, 27(37): 5075-5080.
28. Salon C, Moro D, Lantuejoul S, et al. E-cadherin-beta-catenin adhesion complex in neuroendocrine tumors of the lung: a suggested role upon local invasion and metastasis. Hum Pathol, 2004, 35(9): 1148-1155.
29. Chen XF, Zhang HT, Qi QY, et al. Expression of E-cadherin and nm23 is associated with the clinicopathological factors of human non-small cell lung cancer in China. Lung Cancer, 2005, 48(l): 69-76.
30. Ma W, Chen J, Xue X, et al. Alteration in gene expression profile and biological behavior in human lung cancer cell line NL9980 by nm23-Hl gene silencing. Biochem Biophys Res Commun, 2008, 371 (3): 425-430.
31. De Wever O, Pauwels P, De Craene B, et al. Molecular and pathological signatures of epithelial-mesenchymal transitions at the cancer invasion front. Histochem Cell Biol, 2008, 130(3): 481-494.
32. Camara J, Jarai G. Epithelial-mesenchymal transition in primary human bronchial epithelial cells is Smad-dependent and enhanced by fibronectin and TNF-alpha. Fibrog Tissue Repair, 2010, 3(l): 2.
33. Kasai H, Allen JT, Mason RM, et al. TGF-betal induces human alveolar epithelial to mesenchymal cell transition (EMT). Respir Res, 2005, 6: 56.
34. de Herreros AG, Peiro S, Nassour M, et al. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia, 2010, 15(2): 135-147.
35. Yilmaz M, Christofori G. EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev, 2009, 28(1-2): 15-33.
36. Becker KF, Rosivatz E, Blechschmidt K, et al. Analysis of the E-cadherin repressor Snail in primary human cancers. Cells Tissues Organs, 2007, 185(1-3): 204-212.
37. Barrallo-Gimeno A, Nieto MA The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development, 2005, 132(14): 3151-3161.
38. Morita T, Mayanagi T, Sobue K. Dual roles of myocardin-related transcription factors in epithelial mesenchymal transition via slug induction and actin remodeling. J Cell Biol, 2007, 179(5): 1027-1042.
39. Venkov CD, Link AJ, Jennings JL, et al. A proximal activator of transcription in epithelial-mesenchymal transition. J Clin Invest, 2007, 117(2): 482-491.
40. Zavadil J, Bottinger EP. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene, 2005, 24(37): 5764-5774.
41. Huber MA, Azoitei N, Baumann B, et al. NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J Clin Invest, 2004, 114(4): 569-581.
42. Huber MA, Kraut N, Beug H. Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol, 2005, 17(5): 548-558.
43. Kalluri R. EMT: when epithelial cells decide to become mesenchymal-like cells. J Clin Invest, 2009, 119(6): 1417-1419.
44. Howard EW, Camm KD, Wong YC, et al. E-cadherin upregulation as a therapeutic goal in cancer treatment. Mini Rev Med Chem, 2008, 8(5): 496-518.
45. Juarez P, Guise TA. Tgf-Beta pathway as a therapeutic target in bone metastases. Curr PharmDes, 2010, 16(11): 1301-1312.
46. Wendt MK, Schiemann WP Therapeutic targeting of the focal adhesion complex prevents oncogenic TGF-beta signaling and metastasis. Breast Cancer Res, 2009, 11 (5): R68.